Edition:
United States

Valeant Pharmaceuticals International Inc (VRX.N)

VRX.N on New York Stock Exchange

22.30USD
29 Jul 2016
Change (% chg)

$-0.83 (-3.59%)
Prev Close
$23.13
Open
$22.85
Day's High
$23.06
Day's Low
$22.23
Volume
2,062,592
Avg. Vol
3,837,839
52-wk High
$263.70
52-wk Low
$18.55

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 1.76 December 30 Jul 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 1 1 2 2
(3) HOLD 11 11 10 9
(4) UNDERPERFORM 5 5 5 5
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.90 2.90 2.85 2.84

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 13 2,541.60 2,763.89 2,473.60 3,335.32
Quarter Ending Dec-16 13 2,659.82 2,839.46 2,573.50 3,560.10
Year Ending Dec-16 20 10,025.80 10,575.60 9,882.00 13,270.30
Year Ending Dec-17 20 10,491.00 11,940.00 9,551.00 14,245.60
Earnings (per share)
Quarter Ending Sep-16 17 1.76 1.95 1.53 4.20
Quarter Ending Dec-16 17 2.00 2.31 1.51 4.66
Year Ending Dec-16 20 6.56 6.92 5.53 16.11
Year Ending Dec-17 20 7.83 10.21 5.52 18.59
LT Growth Rate (%) 3 9.30 14.10 1.30 31.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 2,380.21 2,369.70 10.51 0.44
Quarter Ending Dec-15 2,751.67 2,788.70 37.03 1.35
Quarter Ending Sep-15 2,779.92 2,786.80 6.88 0.25
Quarter Ending Jun-15 2,540.42 2,732.40 191.98 7.56
Quarter Ending Mar-15 2,152.05 2,190.90 38.85 1.81
Earnings (per share)
Quarter Ending Mar-16 1.37 1.27 0.10 7.52
Quarter Ending Dec-15 2.61 2.50 0.11 4.03
Quarter Ending Sep-15 2.69 2.74 0.05 1.91
Quarter Ending Jun-15 2.46 2.56 0.10 4.18
Quarter Ending Mar-15 2.34 2.36 0.02 0.96

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 2,541.60 2,543.37 2,521.26 2,877.62 3,335.32
Quarter Ending Dec-16 2,659.82 2,662.21 2,638.30 3,030.53 3,560.10
Year Ending Dec-16 10,025.80 10,029.50 10,002.60 10,870.80 13,270.30
Year Ending Dec-17 10,491.00 10,519.90 10,522.80 11,602.80 14,245.60
Earnings (per share)
Quarter Ending Sep-16 1.76 1.76 1.76 2.34 4.20
Quarter Ending Dec-16 2.00 2.00 1.98 2.62 4.66
Year Ending Dec-16 6.56 6.58 6.62 8.52 16.11
Year Ending Dec-17 7.83 7.93 7.85 10.39 18.59

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 1 4 1
Quarter Ending Dec-16 0 1 4 1
Year Ending Dec-16 0 1 2 3
Year Ending Dec-17 0 1 2 3
Earnings
Quarter Ending Sep-16 0 2 2 4
Quarter Ending Dec-16 2 0 5 2
Year Ending Dec-16 0 2 0 5
Year Ending Dec-17 0 1 1 3

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Stock Traders Daily
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.